Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 16-Sep-24 4:17 PM View:  | Sato Vicki L Director | Denali Therapeutics Inc. (DNLI) | 13-Sep-24 | Sale (Planned) | 1,020 | $30.00 | $30,600.00 | (< 1%) 116.18K to 115.16K | |
| 04-Sep-24 6:26 PM View: | Sato Vicki L Director | Denali Therapeutics Inc. (DNLI) | 03-Sep-24 | Sale (Planned) | 3,080 | $25.00 | $77,007.20 | (3%) 119.26K to 116.18K | |
| 15-Aug-24 4:09 PM View: | Ho Carole Chief Medical Officer | Denali Therapeutics Inc. (DNLI) | 13-Aug-24 | Sale | 2,337 | $22.89 | $53,493.90 | (< 1%) 351.82K to 349.49K | |
| 15-Aug-24 4:10 PM View: | Schuth Alexander O. COFO and Secretary | Denali Therapeutics Inc. (DNLI) | 13-Aug-24 | Sale | 2,272 | $22.89 | $52,006.10 | (< 1%) 712.44K to 710.17K | |
| 03-Jul-24 9:13 PM View: | Krognes Steve E. Director | Denali Therapeutics Inc. (DNLI) | 01-Jul-24 | Sale (Planned) | 30,000 | $22.12 | $663,668.00 | (3%) 902.62K to 872.62K | |
| 03-Jul-24 9:13 PM View: | Sato Vicki L Director | Denali Therapeutics Inc. (DNLI) | 01-Jul-24 | Sale (Planned) | 3,080 | $22.14 | $68,203.60 | (3%) 122.34K to 119.26K | |
| 03-Jul-24 9:13 PM View: | Krognes Steve E. Director | Denali Therapeutics Inc. (DNLI) | 13-Jun-24 | Sale | 688 | $21.79 | $14,991.50 | (< 1%) 891.52K to 890.84K | |
| 10-Jun-24 8:06 PM View: | Cook Jennifer E. Director | Denali Therapeutics Inc. (DNLI) | 06-Jun-24 | Sale (Planned) | 1,458 | $21.73 | $31,682.30 | (7%) 21.5K to 20.04K | |
| 04-Jun-24 6:20 PM View: | Klein Peter S Director | Denali Therapeutics Inc. (DNLI) | 31-May-24 | Grant | 5,967 | -- | -- | 38% 15.53K to 21.5K | |
| 04-Jun-24 6:31 PM View: | Tessier-Lavigne Marc Director | Denali Therapeutics Inc. (DNLI) | 31-May-24 | Grant | 5,967 | -- | -- | < 1% 2.11M to 2.12M | |
| 04-Jun-24 6:33 PM View: | Krognes Steve E. Director | Denali Therapeutics Inc. (DNLI) | 31-May-24 | Grant | 5,967 | -- | -- | < 1% 897.34K to 903.31K | |
| 04-Jun-24 6:30 PM View: | Sato Vicki L Director | Denali Therapeutics Inc. (DNLI) | 31-May-24 | Grant | 5,967 | -- | -- | 5% 116.37K to 122.34K | |
| 04-Jun-24 6:32 PM View: | Thornberry Nancy Director | Denali Therapeutics Inc. (DNLI) | 31-May-24 | Grant | 5,967 | -- | -- | 47% 12.71K to 18.68K | |
| 04-Jun-24 6:28 PM View: | Flatley Jay T Director | Denali Therapeutics Inc. (DNLI) | 31-May-24 | Grant | 5,967 | -- | -- | 2% 340.53K to 346.5K | |
| 04-Jun-24 6:27 PM View: | Harris Erik Director | Denali Therapeutics Inc. (DNLI) | 31-May-24 | Grant | 5,967 | -- | -- | 54% 11.09K to 17.05K | |
| 04-Jun-24 6:29 PM View: | Schenkein David P Director | Denali Therapeutics Inc. (DNLI) | 31-May-24 | Grant | 5,967 | -- | -- | 8% 72.99K to 78.96K | |
| 04-Jun-24 6:30 PM View: | Cook Jennifer E. Director | Denali Therapeutics Inc. (DNLI) | 31-May-24 | Grant | 5,967 | -- | -- | 38% 15.53K to 21.5K | |
| 17-May-24 4:28 PM View: | Sato Vicki L Director | Denali Therapeutics Inc. (DNLI) | 15-May-24 | Sale (Planned) | 1,674 | $20.39 | $34,132.90 | (1%) 118.04K to 116.37K | |
| 17-Apr-24 5:14 PM View: | Sato Vicki L Director | Denali Therapeutics Inc. (DNLI) | 15-Apr-24 | Sale (Planned) | 1,666 | $18.29 | $30,471.10 | (1%) 119.71K to 118.04K | |
| 02-Apr-24 6:07 PM View: | Krognes Steve E. Director | Denali Therapeutics Inc. (DNLI) | 01-Apr-24 | Sale (Planned) | 92,500 | $20.50 | $1,896,250.00 | (9%) 989.84K to 897.34K | |
| 29-Mar-24 5:59 PM View: | Watts Ryan J. President and CEO Director | Denali Therapeutics Inc. (DNLI) | 29-Mar-24 | Gift | 40,000 | -- | -- | (2%) 2.48M to 2.44M | |
| 19-Mar-24 4:27 PM View: | Sato Vicki L Director | Denali Therapeutics Inc. (DNLI) | 15-Mar-24 | Sale (Planned) | 1,666 | $20.10 | $33,486.60 | (1%) 121.38K to 119.71K | |
| 20-Feb-24 5:38 PM View: | Sato Vicki L Director | Denali Therapeutics Inc. (DNLI) | 15-Feb-24 | Sale (Planned) | 1,666 | $18.37 | $30,604.40 | (1%) 123.04K to 121.38K | |
| 15-Feb-24 9:14 PM View: | Ho Carole Chief Medical Officer | Denali Therapeutics Inc. (DNLI) | 14-Feb-24 | Sale (Planned) | 1,405 | $17.79 | $24,995.00 | (< 1%) 353.23K to 351.82K | |
| 15-Feb-24 9:14 PM View: | Schuth Alexander O. COFO and Secretary | Denali Therapeutics Inc. (DNLI) | 14-Feb-24 | Sale (Planned) | 20,128 | $17.66 | $355,460.00 | (3%) 731.22K to 711.09K | |
| 15-Feb-24 9:15 PM View: | Watts Ryan J. President and CEO Director | Denali Therapeutics Inc. (DNLI) | 13-Feb-24 | Sale | 9,589 | $17.29 | $165,794.00 | (< 1%) 2.49M to 2.48M | |
| 15-Feb-24 9:14 PM View: | Ho Carole Chief Medical Officer | Denali Therapeutics Inc. (DNLI) | 13-Feb-24 | Sale | 2,784 | $17.29 | $48,135.40 | (< 1%) 356.01K to 353.23K | |
| 15-Feb-24 9:16 PM View: | Krognes Steve E. Director | Denali Therapeutics Inc. (DNLI) | 13-Feb-24 | Sale | 2,750 | $17.29 | $47,547.50 | (< 1%) 992.59K to 989.84K | |
| 15-Feb-24 9:14 PM View: | Schuth Alexander O. COFO and Secretary | Denali Therapeutics Inc. (DNLI) | 13-Feb-24 | Sale | 2,716 | $17.29 | $46,959.60 | (< 1%) 733.93K to 731.22K | |
| 12-Feb-24 4:48 PM View: | Schuth Alexander O. COFO and Secretary | Denali Therapeutics Inc. (DNLI) | 08-Feb-24 | Option Exercise | 50,000 | $0.68 | $34,000.00 | 7% 683.93K to 733.93K | |
| 18-Jan-24 6:26 PM View: | Sato Vicki L Director | Denali Therapeutics Inc. (DNLI) | 16-Jan-24 | Sale (Planned) | 1,666 | $18.42 | $30,687.70 | (1%) 124.71K to 123.04K | |
| 12-Jan-24 8:18 PM View: | Ho Carole Chief Medical Officer | Denali Therapeutics Inc. (DNLI) | 10-Jan-24 | Sale (Planned) | 4,668 | $19.02 | $88,785.40 | (1%) 360.68K to 356.01K | |
| 11-Jan-24 5:28 PM View: | Watts Ryan J. President and CEO Director | Denali Therapeutics Inc. (DNLI) | 09-Jan-24 | Sale | 7,818 | $19.78 | $154,640.00 | (< 1%) 2.5M to 2.49M | |
| 09-Jan-24 7:33 PM View: | Watts Ryan J. President and CEO Director | Denali Therapeutics Inc. (DNLI) | 05-Jan-24 | Sale | 17,483 | $19.43 | $339,695.00 | (< 1%) 2.52M to 2.5M | |
| 09-Jan-24 7:34 PM View: | Krognes Steve E. Director | Denali Therapeutics Inc. (DNLI) | 05-Jan-24 | Sale | 3,208 | $19.43 | $62,331.40 | (< 1%) 995.8K to 992.59K | |
| 09-Jan-24 7:34 PM View: | Schuth Alexander O. COFO and Secretary | Denali Therapeutics Inc. (DNLI) | 05-Jan-24 | Sale | 9,972 | $19.43 | $193,756.00 | (1%) 693.91K to 683.93K | |
| 09-Jan-24 7:35 PM View: | Ho Carole Chief Medical Officer | Denali Therapeutics Inc. (DNLI) | 05-Jan-24 | Sale Duplicate | 9,972 | $19.43 | $193,756.00 | (3%) 370.65K to 360.68K | |
| 05-Jan-24 5:56 PM View: | Watts Ryan J. President and CEO Director | Denali Therapeutics Inc. (DNLI) | 03-Jan-24 | Grant | 89,520 | -- | -- | 4% 2.43M to 2.52M | |
| 05-Jan-24 5:57 PM View: | Ho Carole Chief Medical Officer | Denali Therapeutics Inc. (DNLI) | 03-Jan-24 | Grant | 53,720 | -- | -- | 17% 316.93K to 370.65K | |
| 05-Jan-24 5:57 PM View: | Schuth Alexander O. COFO and Secretary | Denali Therapeutics Inc. (DNLI) | 03-Jan-24 | Grant | 53,720 | -- | -- | 8% 640.19K to 693.91K | |
| 18-Dec-23 7:30 PM View: | Sato Vicki L Director | Denali Therapeutics Inc. (DNLI) | 15-Dec-23 | Sale (Planned) | 1,666 | $23.39 | $38,967.70 | (1%) 126.37K to 124.71K | |
| 16-Nov-23 6:14 PM View: | Sato Vicki L Director | Denali Therapeutics Inc. (DNLI) | 15-Nov-23 | Sale (Planned) | 1,666 | $19.13 | $31,870.60 | (1%) 128.04K to 126.37K | |
| 18-Oct-23 4:44 PM View: | Sato Vicki L Director | Denali Therapeutics Inc. (DNLI) | 16-Oct-23 | Sale (Planned) | 1,666 | $20.66 | $34,419.60 | (1%) 129.71K to 128.04K | |
| 19-Sep-23 4:45 PM View: | Sato Vicki L Director | Denali Therapeutics Inc. (DNLI) | 15-Sep-23 | Sale (Planned) | 1,666 | $23.62 | $39,347.60 | (1%) 131.37K to 129.71K | |
| 25-Aug-23 5:30 PM View: | Ho Carole Chief Medical Officer | Denali Therapeutics Inc. (DNLI) | 23-Aug-23 | Sale (Planned) | 2,522 | $23.22 | $58,560.80 | (< 1%) 319.45K to 316.93K | |
| 25-Aug-23 5:36 PM View: | Schuth Alexander O. COFO and Secretary | Denali Therapeutics Inc. (DNLI) | 23-Aug-23 | Sale (Planned) | 2,522 | $23.17 | $58,434.70 | (< 1%) 642.71K to 640.19K | |
| 23-Aug-23 4:33 PM View: | Schuth Alexander O. COFO and Secretary | Denali Therapeutics Inc. (DNLI) | 21-Aug-23 | Sale | 2,478 | $22.59 | $55,978.00 | (< 1%) 645.19K to 642.71K | |
| 23-Aug-23 4:31 PM View: | Krognes Steve E. Director | Denali Therapeutics Inc. (DNLI) | 21-Aug-23 | Sale | 1,419 | $22.60 | $32,069.40 | (< 1%) 997.22K to 995.8K | |
| 23-Aug-23 4:32 PM View: | Watts Ryan J. President and CEO Director | Denali Therapeutics Inc. (DNLI) | 21-Aug-23 | Sale | 2,309 | $22.59 | $52,160.30 | (< 1%) 2.43M to 2.43M | |
| 23-Aug-23 4:34 PM View: | Ho Carole Chief Medical Officer | Denali Therapeutics Inc. (DNLI) | 21-Aug-23 | Sale | 2,478 | $22.60 | $56,002.80 | (< 1%) 321.93K to 319.45K |
